These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Effects of different treatments for hyperthyroidism on the hypothalamic-pituitary-adrenal axis. Lizcano F, Salvador J. Clin Exp Pharmacol Physiol; 2008 Sep; 35(9):1085-90. PubMed ID: 18505442 [Abstract] [Full Text] [Related]
3. Evaluation of hypothalamo-pituitary-adrenocortical function in children by human corticotropin-releasing hormone (MCI-028) test. Tanaka T, Hibi I, Shimizu N, Imura H, Tanaka K, Fukata J, Fujieda K, Ichimura T, Kuribayashi T, Ito K. Endocr J; 1993 Oct; 40(5):581-9. PubMed ID: 7951524 [Abstract] [Full Text] [Related]
4. The effect of pulsatile human corticotropin-releasing hormone administration on the adrenal insufficiency that follows cure of Cushing's disease. Avgerinos PC, Nieman LK, Oldfield EH, Loughlin T, Barnes KM, Loriaux DL, Cutler GB. J Clin Endocrinol Metab; 1989 May; 68(5):912-6. PubMed ID: 2541160 [Abstract] [Full Text] [Related]
5. Recovery from glucocorticoid inhibition of the responses to corticotrophin-releasing hormone. Watson AC, Rosenfield RL, Fang VS. Clin Endocrinol (Oxf); 1988 May; 28(5):471-7. PubMed ID: 2850875 [Abstract] [Full Text] [Related]
6. Effect of acute and prolonged mineralocorticoid receptor blockade on spontaneous and stimulated hypothalamic-pituitary-adrenal axis in humans. Berardelli R, Karamouzis I, Marinazzo E, Prats E, Picu A, Giordano R, Ghigo E, Arvat E. Eur J Endocrinol; 2010 Jun; 162(6):1067-74. PubMed ID: 20219855 [Abstract] [Full Text] [Related]
7. Assessment of stimulated and spontaneous adrenocorticotropin secretory dynamics identifies distinct components of cortisol feedback inhibition in healthy humans. Dorin RI, Ferries LM, Roberts B, Qualls CR, Veldhuis JD, Lisansky EJ. J Clin Endocrinol Metab; 1996 Nov; 81(11):3883-91. PubMed ID: 8923833 [Abstract] [Full Text] [Related]
8. Classification of polycystic ovary syndrome into three types according to response to human corticotropin-releasing hormone. Kondoh Y, Uemura T, Ishikawa M, Yokoi N, Hirahara F. Fertil Steril; 1999 Jul; 72(1):15-20. PubMed ID: 10428142 [Abstract] [Full Text] [Related]
9. Psychological and endocrine responses to psychosocial stress and dexamethasone/corticotropin-releasing hormone in healthy postmenopausal women and young controls: the impact of age and a two-week estradiol treatment. Kudielka BM, Schmidt-Reinwald AK, Hellhammer DH, Kirschbaum C. Neuroendocrinology; 1999 Dec; 70(6):422-30. PubMed ID: 10657735 [Abstract] [Full Text] [Related]
10. Effect of altered thyroid hormone levels on hypothalamic-pituitary-adrenal function. Kamilaris TC, DeBold CR, Pavlou SN, Island DP, Hoursanidis A, Orth DN. J Clin Endocrinol Metab; 1987 Nov; 65(5):994-9. PubMed ID: 3499449 [Abstract] [Full Text] [Related]
11. Adrenocorticotropic hormone and cortisol concentrations after corticotropin-releasing hormone stimulation testing in cats administered methylprednisolone. Crager CS, Dillon AR, Kemppainen RJ, Brewer WG, Angarano DW. Am J Vet Res; 1994 May; 55(5):704-9. PubMed ID: 8067621 [Abstract] [Full Text] [Related]
12. Gonadotropin-releasing hormone agonist in premenopausal women does not alter hypothalamic-pituitary-adrenal axis response to corticotropin-releasing hormone. Gavin KM, Shea KL, Gibbons E, Wolfe P, Schwartz RS, Wierman ME, Kohrt WM. Am J Physiol Endocrinol Metab; 2018 Aug 01; 315(2):E316-E325. PubMed ID: 29631362 [Abstract] [Full Text] [Related]
13. A comparison of the naloxone test with ovine CRH and insulin hypoglycaemia in the evaluation of the hypothalamic-pituitary-adrenal axis in normal man. Inder WJ, Ellis MJ, Evans MJ, Donald RA. Clin Endocrinol (Oxf); 1995 Oct 01; 43(4):425-31. PubMed ID: 7586616 [Abstract] [Full Text] [Related]
14. Corticotropin and cortisol response to human CRH as a probe for HPA system integrity in major depressive disorder. Lesch KP, Laux G, Schulte HM, Pfüller H, Beckmann H. Psychiatry Res; 1988 Apr 01; 24(1):25-34. PubMed ID: 2839859 [Abstract] [Full Text] [Related]
15. The combined dexamethasone-suppression/CRH-stimulation test in alcoholics during and after acute withdrawal. Hundt W, Zimmermann U, Pöttig M, Spring K, Holsboer F. Alcohol Clin Exp Res; 2001 May 01; 25(5):687-91. PubMed ID: 11371718 [Abstract] [Full Text] [Related]
16. Hypothalamo-pituitary-adrenal axis dysfunction in chronic fatigue syndrome, and the effects of low-dose hydrocortisone therapy. Cleare AJ, Miell J, Heap E, Sookdeo S, Young L, Malhi GS, O'Keane V. J Clin Endocrinol Metab; 2001 Aug 01; 86(8):3545-54. PubMed ID: 11502777 [Abstract] [Full Text] [Related]
17. Thyroid Hormone Deficiency Suppresses Fetal Pituitary-Adrenal Function Near Term: Implications for the Control of Fetal Maturation and Parturition. Camm EJ, Inzani I, De Blasio MJ, Davies KL, Lloyd IR, Wooding FBP, Blache D, Fowden AL, Forhead AJ. Thyroid; 2021 Jun 01; 31(6):861-869. PubMed ID: 33126831 [Abstract] [Full Text] [Related]
18. Evaluation of corticotropin releasing factor stimulation and basal markers of hypothalamic-pituitary-adrenal axis suppression in asthmatic patients. Clark DJ, Lipworth BJ. Chest; 1997 Nov 05; 112(5):1248-52. PubMed ID: 9367464 [Abstract] [Full Text] [Related]
19. Somatostatin treatment reduces the exaggerated response of adrenocorticotropin hormone and cortisol to corticotropin-releasing hormone in polycystic ovary syndrome. Lanzone A, Fulghesu AM, Guido M, Cucinelli F, Caruso A, Mancuso S. Fertil Steril; 1997 Jan 05; 67(1):34-9. PubMed ID: 8986680 [Abstract] [Full Text] [Related]
20. Human corticotropin-releasing hormone test in patients with hypothalamo-pituitary-adrenocortical disorders. Fukata J, Shimizu N, Imura H, Hibi I, Tanaka K, Tanaka T, Nakagawa S, Takebe K, Kimura K, Yoshinaga K. Endocr J; 1993 Oct 05; 40(5):597-606. PubMed ID: 7951526 [Abstract] [Full Text] [Related] Page: [Next] [New Search]